drugset
drugset / Trial / NCT04163458

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

NCT04163458 ↗

Phase 3 Completed 405 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Development of multiple follicles and pregnancy in ovulatory women undergoing controlled ovarian stimulation as part of an assisted reproductive technology (ART) cycle.

Timeline

Start
2019-10-25
Primary completion
2021-05-28
Completion
2021-07-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Menopur Protein / enzyme biologic 225 iu Subcutaneous

Indications

infertility disorder